SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-058858
Filing Date
2023-11-03
Accepted
2023-11-03 16:30:09
Documents
12
Period of Report
2023-10-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20231030.htm   iXBRL 8-K 54858
  Complete submission text file 0000950170-23-058858.txt   186577

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrn-20231030_pre.xml EX-101.PRE 11952
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrn-20231030_lab.xml EX-101.LAB 19119
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrn-20231030.xsd EX-101.SCH 2480
6 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20231030_htm.xml XML 5152
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 231376807
SIC: 2834 Pharmaceutical Preparations